Developer of a bio-medicine technology designed to help in complex painkiller drug development. The company's technology is used in performing phase III of clinical studies on an increased number of patients, including the monitoring of undesired effects and development of documentation to register a new complex pain killer patented, enabling patients to access next-generation pain-killers.